Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2012
02/21/2012CA2447033C Phosphotriesterase from agrobacterium radiobacter p230
02/21/2012CA2439123C Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier
02/21/2012CA2420413C Plant polynucleotides encoding novel vacuolar na+/h+ antiporters
02/21/2012CA2412460C Human monoclonal antibody against hepatitis c virus e2 glycoprotein
02/21/2012CA2409983C Viral variants and methods of using same
02/21/2012CA2407680C Dendritic cell co-stimulator molecules
02/21/2012CA2406626C Hemostatically active vwf-containing preparation and process for the preparation thereof
02/21/2012CA2386506C Isolation of precursor cells and their use for tissue repair
02/21/2012CA2373300C Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
02/21/2012CA2350185C Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla
02/21/2012CA2338250C Lafora's disease gene
02/21/2012CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
02/21/2012CA2302866C Genetically modified tumor-targeted bacteria with reduced virulence
02/21/2012CA2297303C Novel peptides and polypeptides useful for regenerating the nervous system
02/21/2012CA2296841C Tropoelastin derivatives
02/21/2012CA2269085C Rainbow trout il1.beta.; encoding nucleic acid; materials and methods
02/21/2012CA2263835C Stimulus-inducible i (kappa)b kinase [ikk] signalsome
02/21/2012CA2158936C Compositions and methods for utilizing conditionally lethal genes
02/16/2012WO2012021907A2 Vincristine immunoassay
02/16/2012WO2012021803A1 Method for using ref protein as a targeted reca-dependent nuclease
02/16/2012WO2012021512A2 Erythrocyte-binding therapeutics
02/16/2012WO2012021500A2 Antipathogenic proteins and methods of use
02/16/2012WO2012021088A1 A novel conjugate of granulocyte colony-stimulating factor (g-csf) with polyethylene glycol
02/16/2012WO2012020843A1 Transgenic animal, transformed stem cell, and use thereof
02/16/2012WO2012020326A1 Adjuvanted vaccines for serogroup b meningococcus
02/16/2012WO2012020289A2 Specific active site inhibitors of enzymes or substrate binding partners and methods of producing same
02/16/2012WO2012020218A1 Compositions and methods for inducing platelet aggregation
02/16/2012WO2012020124A1 Vaccine engineering
02/16/2012WO2012020057A1 Selective manufacture of recombinant neurotoxin polypeptides
02/16/2012WO2012019619A1 Fluorescent proteins with increased activity in cells
02/16/2012WO2012019437A1 Bladder cancer tumor marker, antibiotic and application thereof
02/16/2012WO2012019423A1 Angiogenesis inhibitor, method for purifying thereof and pharmaceutical composition comprising thereof
02/16/2012WO2011160630A3 Glucagon analogues
02/16/2012WO2011159153A3 Inducible promoter and its use
02/16/2012WO2011112906A3 Novel immunogens and methods for discovery and screening thereof
02/16/2012WO2011109104A3 Molecular clone of hiv-1
02/16/2012WO2011091419A3 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery
02/16/2012WO2011091350A9 Methods & compositions for improving protein production
02/16/2012WO2011004148A8 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis
02/16/2012WO2005110456A8 T-cell death-inducing epitopes
02/16/2012WO2002085309A9 Composition, formulations & kits for treatment of respiratory & lung disease with anti-sense oligonucleotides & a bronchodilating agent
02/16/2012US20120042410 Abscisic acid carrier gene and transgenic plant expressing the same
02/16/2012US20120042400 Rtd receptor
02/16/2012US20120042051 System and Method for Monitoring and Analyzing Internet Traffic
02/16/2012US20120041182 Water Soluble Cholesterol Derivatives
02/16/2012US20120041181 Fusion proteins forming trimers
02/16/2012US20120041179 Preparation and Purification of Subunit Vaccine for Neisseria Meningitidis (NM) Group B Isolates
02/16/2012US20120041178 Coenzyme Q10 Nanoparticles, Preparation Method Thereof and Composition Containing Said Nanoparticles
02/16/2012US20120041177 Method of producing polymers of spider silk proteins
02/16/2012US20120041176 Ucp4
02/16/2012US20120041175 Novel autography regulators atg14l and rubicon
02/16/2012US20120041171 Process for the production of a recombinant polypeptide of interest
02/16/2012US20120040918 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
02/16/2012US20120040917 Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
02/16/2012US20120040915 Peptides and nanoparticles for therapeutic and diagnostic applications
02/16/2012US20120040909 Identification of novel antagonist toxins of t-type calcium channel for analgesic purposes
02/16/2012US20120040906 Protein targets in disease
02/16/2012US20120040905 Means for purifying a coagulation protein, and methods for implementing same
02/16/2012US20120040900 Compositions of and methods of using ligand dimers
02/16/2012US20120040894 Mini-Hepcidin Peptides and Methods of Using thereof
02/16/2012US20120040891 Hiv fusion inhibitor peptides with improved biological properties
02/16/2012US20120040886 Analogues of Neuropeptide Y Having Proline Substitution At Position 34
02/16/2012US20120040885 Analogues of Neuropeptide Y Having At Least One Synthetic Amino Acid Substitution
02/16/2012US20120040474 Glycan-Specific Analytical Tools
02/16/2012US20120040456 Methods of gene therapy using nucleic acid sequences for atp-binding cassette transporter
02/16/2012US20120040451 Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
02/16/2012US20120040433 Live, oral vaccine for protection against shigella dysenteriae serotype 1
02/16/2012US20120040400 Novel Permanent Human Cell Line
02/16/2012US20120040385 Coagulogen raw material, process for producing the same, and method and apparatus for measuring physiologically active substance of biological origin using the same
02/16/2012US20120040378 Meprobromate Immunoassay
02/16/2012US20120040377 Recognition of cyp2e1 epitopes
02/16/2012US20120040376 Lung cancer diagnostic polypeptide, method for detecting lung cancer, and method for evaluating therapeutic effect
02/16/2012US20120040374 Method for detecting renal disease comprising measuring human megalin in urine
02/16/2012US20120040368 Mutated voltage-gated sodium channel nav alpha subunit for identification of modulators
02/16/2012US20120040366 Compositions, methods and uses for disease diagnosis
02/16/2012US20120040365 New competence stimulating peptide
02/16/2012US20120040363 Method for enriching a prokaryotic dna
02/16/2012US20120040345 2-Nitrobenzyl-Modified Ribonucleotides
02/16/2012US20120040119 Novel collagen materials and methods for obtaining same
02/16/2012US20120039993 Detection of Gene Expression
02/16/2012US20120039989 Erythrocyte-binding therapeutics
02/16/2012US20120039942 Outer membrane vesicles and uses thereof
02/16/2012US20120039941 Engineered botulinum neurotoxin
02/16/2012US20120039938 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use
02/16/2012US20120039936 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
02/16/2012US20120039925 Tuberculosis tb vaccine to prevent reactivation
02/16/2012US20120039924 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
02/16/2012US20120039923 Modified HIV-1 Envelope Proteins
02/16/2012US20120039921 Poultry viral materials and methods related thereto
02/16/2012US20120039919 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods
02/16/2012US20120039914 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor
02/16/2012US20120039908 Control of Protein Glycosylation and Compositions and Methods Relating Thereto
02/16/2012US20120039902 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
02/16/2012US20120039893 Mutant smoothened and methods of using the same
02/16/2012US20120039891 Methods for diagnosing cancer and decreasing metastasis by cancer cells
02/16/2012US20120039890 Methods of treatment using antibodies to neutrokine-alpha
02/16/2012US20120039879 Streptavidin having low immunogenicity and use thereof
02/16/2012US20120039869 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
02/16/2012US20120039843 Conjugates of a polypeptide and an oligosaccharide
02/16/2012US20120039813 Intrinsically colored, luminescent silk fibroin and a method of producing the same
1 ... 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 ... 2916